Avidity Partners Management LP Blueprint Medicines Corp Transaction History

Avidity Partners Management LP

$445 Million
Q1 2025

A detailed history of Avidity Partners Management LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Avidity Partners Management LP holds 68,500 shares of BPMC stock, worth $8.87 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

68,500

Previous 176,600 61.21%

Holding current value

$8.87 Million

Previous $15.4 Million 60.64%

% of portfolio

1.36%

Previous 1.74%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$86.69 - $115.63 $9.37 Million - $12.5 Million	-108,100 Reduced 61.21%	68,500 $6.06 Million
Q4 2024 Feb 14, 2025	SELL	$82.48 - $101.39 $11.4 Million - $14 Million	-138,400 Reduced 43.94%	176,600 $15.4 Million
Q3 2024 Nov 14, 2024	SELL	$84.1 - $120.5 $5.72 Million - $8.19 Million	-68,000 Reduced 17.75%	315,000 $29.1 Million
Q2 2024 Aug 14, 2024	SELL	$85.18 - $108.78 $3.66 Million - $4.68 Million	-43,000 Reduced 10.09%	383,000 $41.3 Million
Q1 2024 May 15, 2024	SELL	$73.17 - $99.79 $13.8 Million - $18.9 Million	-189,000 Reduced 30.73%	426,000 $40.4 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $6 Million - $12.7 Million	-136,600 Reduced 18.17%	615,000 $56.7 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $15.8 Million - $22.2 Million	336,600 Added 81.11%	751,600 $37.7 Million
Q2 2023 Aug 14, 2023	BUY	$42.2 - $66.37 $17.5 Million - $27.5 Million	415,000 New	415,000 $26.2 Million
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $13.2 Million - $20.4 Million	-291,184 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$54.1 - $110.08 $38.1 Million - $77.5 Million	-703,816 Reduced 70.74%	291,184 $18.6 Million
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $15.4 Million - $18.9 Million	163,000 Added 19.59%	995,000 $107 Million
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $21.8 Million - $29.4 Million	268,800 Added 47.73%	832,000 $85.5 Million
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $1.42 Million - $1.74 Million	17,200 Added 3.15%	563,200 $49.5 Million
Q1 2021 May 17, 2021	BUY	$90.71 - $108.28 $27.8 Million - $33.1 Million	306,000 Added 127.5%	546,000 $53.1 Million
Q4 2020 Feb 16, 2021	BUY	$92.08 - $124.48 $22.1 Million - $29.9 Million	240,000 New	240,000 $26.9 Million

Others Institutions Holding BPMC

# of Institutions

379

Shares Held

67.9M

Call Options Held

1.54M

Put Options Held

1.21M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.73B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Account

Avidity Partners Management LP Blueprint Medicines Corp Transaction History